Teneligliptin NEW
| Price | $30 | $40 |
| Package | 5mg | 10mg |
| Supply Ability: | 10g |
| Update Time: | 2026-06-10 |
Product Details
| Product Name: Teneligliptin | CAS No.: 760937-92-6 |
| Purity: 99.83% | Supply Ability: 10g |
| Release date: 2026/06/10 |
Product Introduction
Bioactivity
| Name | Teneligliptin |
| Description | Teneligliptin (MP-513) is a novel dipeptidyl peptidase 4 (DPP IV) inhibitor for the treatment of type 2 diabetes mellitus with hypoglycemic activity for the study of obesity and diabetes. |
| Kinase Assay | DPP-4 inhibition assay is carried out using either 5 ng purified recombinant human DPP-4 (rhDPP-4), human plasma (20-fold diluted with assay buffer; phosphate-buffered saline (PBS) containing 0.003% Brij-35 solution), or rat plasma (10-fold diluted with assay buffer) Gly-Pro-MCA as a chromogenic substrate as described previously with slight modifications. DPP-4 inhibitors (Teneligliptin, Sitagliptin, and Vildagliptin) are diluted with assay buffer at several concentrations. Twenty microliters of inhibitor solution, 20 μL of the enzyme source, and 20 μL of Gly-Pro-MCA (final concentration, 25 μM) are mixed with 140 μL or 160 μL of assay buffer to initiate the enzyme reaction. After 20 min (rhDPP-4) or 1 h (plasma) at 37°C, the fluorescence intensity of 7-amino-4-methyl-coumarin (AMC) generated from Gly-Pro-MCA is measured using an automated microplate reader at 360 nm excitation and 465 nm emission. The fluorescence intensity of AMC corresponded to DPP-4 activity[1]. |
| In vitro | Teneligliptin inhibits DPP-4 enzyme in a concentration-dependent manner. The IC50 values of Teneligliptin on human recombinant DPP4 (rhDPP-4), human plasma and rat plasma were 0.889 nM, 1.75 nM and 1.35 nM, respectively. The kinetics of enzyme inhibition by Teneligliptin was investigated using Gly-Pro-MCA as the substrate and rhDPP-4 as the enzyme source, and the Ki, Km and Vmax values were 0.406 nM, 24 μM and 6.06 nmol/min, respectively. Teneligliptin inhibited the degradation of GLP-1(7-36)amide with an IC50 value of 2.92 nM. [1] |
| In vivo | In Wistar rats, oral administration of Teneligliptin effectively inhibited plasma DPP-4 with an ED50 value of 0.41 mg/kg, and the inhibitory effect was sustained up to 24 hours after administration. Teneligliptin at a dose of 1 mg/kg significantly reduced triglyceride and free fatty acid fluctuations in an oral fat loading assay in Zucker rats. Zucker rats receiving Teneligliptin orally for two consecutive weeks demonstrated a reduction in blood glucose fluctuations in an oral glycemic load test, as well as a reduction in plasma triglyceride and free fatty acid levels in the non-fasting state. [1] In addition, Teneligliptin improved hepatic histopathological features and reduced intrahepatic triglyceride levels in a mouse model of nonalcoholic fatty liver disease, which was associated with downregulation of hepatic lipid synthesis-related genes induced by AMPK activation. [2] |
| Storage | Store at low temperature,Keep away from moisture Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 20 mg/mL (46.88 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (4.69 mM), Sonication is recommended. |
| Keywords | Teneligliptin | DPP-4 | DPP4 |
| Inhibitors Related | Tripterin | Sitagliptin | Teneligliptin hydrobromide | Sitagliptin phosphate monohydrate | 10-Undecenoic acid | Anagliptin | Aprotinin | 10-Undecenoic acid zinc salt | Vildagliptin | Sitagliptin phosphate | Alloxan monohydrate | 4'-Hydroxychalcone |
| Related Compound Libraries | FDA-Approved & Pharmacopeia Drug Library | Bioactive Compound Library | Approved Drug Library | Protease Inhibitor Library | Drug Repurposing Compound Library | Inhibitor Library | Bioactive Compounds Library Max | NMPA-Approved Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
VIP4Y
|
Henan Aochuang Chemical Co.,Ltd.
|
2025-04-04 | ||
|
Nanjing Fred Technology Co., Ltd
|
2024-11-26 | |||
| $15.00 |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-13 | ||
| $1000.00 |
VIP8Y
|
Career Henan Chemical Co
|
2019-07-06 | |
| $15.00 |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-10 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY